Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma

Fig. 3

Correlations between the immunophenotype and expression of HLA genes and immune checkpoint molecules. a HLA genes (HLA-A, HLA-E, HLA-DPB1, and HLA-DRB5) were differentially expressed in the different groups. b Immune checkpoint genes, including BTLA, LAG3, ICOS, ADORA2A, CD70, PD-L1 (CD274), and TIGIT, were differentially expressed in the different groups

Back to article page